Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Shares, $0.001 par value
-
Shares outstanding
-
15.4M
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
5.29M
-
Shares change
-
+43.9K
-
Total reported value, excl. options
-
$63.2M
-
Value change
-
+$852K
-
Number of buys
-
22
-
Number of sells
-
-29
-
Price
-
$11.95
Significant Holders of Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) as of Q4 2020
71 filings reported holding GRX - Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value as of Q4 2020.
Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.29M shares
of 15.4M outstanding shares and own 34.24% of the company stock.
Largest 10 shareholders include Karpus Management, Inc. (1.3M shares), WELLS FARGO & COMPANY/MN (520K shares), LAZARD ASSET MANAGEMENT LLC (462K shares), MORGAN STANLEY (425K shares), GAMCO INVESTORS, INC. ET AL (298K shares), ROYAL BANK OF CANADA (212K shares), Matisse Capital (206K shares), Cornerstone Advisors, LLC (178K shares), BENNICAS & ASSOCIATES, INC. (170K shares), and UBS Group AG (161K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.